IPI Surfacing panel discussion: The promise of synthetic antibodies and the challenges to universal access

The IPI Surfacing panel discusses the biomedical applications of synthetic antibodies, barriers to competing with animal-derived antibodies and universal access to quality protein tools within the research community at IPI Surfacing on June 15, 2023. Click to view more IPI Surfacing event content.

Panelists:
Errik Anderson, Alloy Therapeutics
Aled Edwards, University of Toronto and the Structural Genomics Consortium
Andrew Kruse, Harvard Medical School
Rob Meijers, Institute for Protein Innovation
Andreas Plückthun, University of Zürich
Meghan Rego, Addgene

 

Host: Ken Fasman, Institute for Protein Innovation
Back To Top